FDA approves Wegovy for CVD risk reduction in people with overweight or obesity and established cardiovascular disease
GLP-1 RA linked to increased residual gastric content before anaesthesia
SASI bypass and OAGB more effective than SG in the treatment of metabolic syndrome
Waist-to-height ratio significantly betters detection of obesity in children and adolescents
Epitomee files weight loss capsule for FDA clearance
AMOS2: Surgery does not improve executive function or memory in adolescents vs. intensive non-surgical treatment
Journal Watch 6/3/2024
FLOW trial: Semaglutide 1.0mg demonstrates 24% reduction in the risk of kidney disease-related events in T2DM and chronic kidney disease patients
Spatz3 Adjustable Gastric Balloon launched in the US
The number of people living with obesity passes one billion
